VivoSeq
Other

Infiltration

0

Pipeline Programs

4

Active Trials

0

Companies Involved

Infiltration is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

16/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

86/100

Attrition Rate

5/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

55

clinical trials

Completed32 · 58%
Unknown status14 · 25%
Recruiting4 · 7%
Withdrawn3 · 5%
Suspended2 · 4%

Trial Activity

55 trials

Comparison of the Analgesic Effect of 2 Shoulder Infiltrations
Recruiting··N/A·NCT05408065·84 enrolled
Surgeon Infiltration QL Block Comparison
Completed··Phase 4·NCT03496610·44 enrolled
Gall Bladder Bed Infiltration Analgesia
Completed··N/A·NCT03693820·70 enrolled
Page 1 of 4

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)